Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial

Radiotherapy and Oncology

Volumn 110, Issue 1, 2014, Pages 114-119

  Yoshioka, Yasuo ^a   Konishi, Koji ^b   Suzuki, Osamu ^a   Nakai, Yasutomo ^a   Isohashi, Fumiaki ^a   Seo, Yuji ^a   Otani, Yuki ^a   Koizumi, Masahiko ^a   Yoshida, Ken ^c   Yamazaki, Hideya ^d   Nonomura, Norio ^a   Ogawa, Kazuhiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

High dose rate (HDR) brachytherapy; Hypofractionation; Monotherapy; Prostate cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ANUS PAIN; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; COLON PERFORATION; CONSTIPATION; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATURIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTOURETHRAL FISTULA; RECTUM HEMORRHAGE; SIGMOID; URETHRA STENOSIS; URETHRA STRICTURE; URETHRAL PAIN; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION; VERY ELDERLY; BLOOD; CLINICAL TRIAL; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION RESPONSE;

KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84896069930     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.015     Document Type: Article

References (31)

1. J.M. Michalski, K. Bae, and M. Roach et al. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22
2. Z.A. Alicikus, Y. Yamada, and Z. Zhang et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer Cancer 117 2011 1429 1437
3. J.E. Sylvester, P.D. Grimm, J. Wong, R.W. Galbreath, G. Merrick, and J.C. Blasko Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I-125 prostate brachytherapy in clinically localized prostate cancer: Seattle experience Int J Radiat Oncol Biol Phys 81 2011 376 381
4. G. Goldner, R. Pötter, and J.J. Battermann et al. Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients Radiother Oncol 103 2012 223 227
5. N.N. Stone, M.M. Stone, B.S. Rosenstein, P. Unger, and R.G. Stock Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy J Urol 185 2011 495 500
6. M. Dattoli, K. Wallner, L. True, J. Cash, and R. Sorace Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features Cancer 110 2007 551 555 (Pubitemid 47106143)
7. R.M. Galalae, G. Kovacs, and J. Schultze et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90 (Pubitemid 34044108)
8. T.P. Mate, J.E. Gottesman, and J. Hatton et al. High dose-rate afterloading Ir-192 prostate brachytherapy: feasibility report Int J Radiat Oncol Biol Phys 41 1998 525 533 (Pubitemid 28275080)
9. Y. Yoshioka, T. Nose, and K. Yoshida et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 48 2000 675 681
10. Y. Yoshioka, T. Nose, and K. Yoshida et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity Int J Radiat Oncol Biol Phys 56 2003 213 220 (Pubitemid 36403694)
11. Y. Yoshioka, K. Konishi, and R.J. Oh et al. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer Radiother Oncol 80 2006 62 68 (Pubitemid 44226435)
12. Y. Yoshioka, K. Konishi, and I. Sumida et al. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions Int J Radiat Oncol Biol Phys 80 2011 469 475
13. K. Konishi, Y. Yoshioka, and F. Isohashi et al. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer Int J Radiat Oncol Biol Phys 75 2009 1003 1007
14. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101 (Pubitemid 29144800)
15. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031 (Pubitemid 32594841)
16. D.J. Brenner, A.A. Martinez, and G.K. Edmundson et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13 (Pubitemid 34041562)
17. J.Z. Wang, M. Guerrero, and X.A. Li How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 2003 194 203 (Pubitemid 36020360)
18. R. Miralbell, S.A. Roberts, and E. Zubizarreta et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 82 2012 e17 e24
19. A. Martinez, I. Pataki, and G. Edmundson et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report Int J Radiat Oncol Biol Phys 49 2001 61 69 (Pubitemid 32041277)
20. T. Martin, D. Baltas, and R. Kurek et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study Strahlenther Onkol 180 2004 225 232 (Pubitemid 38461547)
21. C. Corner, A.M. Rojas, and L. Bryant et al. A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 441 446
22. P. Ghadjar, T. Keller, and C.A. Rentsch et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy Brachytherapy 8 2009 45 51
23. N. Zamboglou, N. Tselis, and D. Baltas et al. High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results Int J Radiat Oncol Biol Phys 85 2013 672 678
24. P. Hoskin, A. Rojas, and G. Lowe et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence Int J Radiat Oncol Biol Phys 82 2012 1376 1384
25. M. Barkati, S.G. Williams, and F. Foroudi et al. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial Int J Radiat Oncol Biol Phys 82 2012 1889 1896
26. M. Ghilezan, A. Martinez, and G. Gustason et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data Int J Radiat Oncol Biol Phys 83 2012 927 932
27. P.J. Prada, I. Jimenez, and H. González-Suárez et al. High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results Brachytherapy 11 2012 105 110
28. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694 (Pubitemid 19194494)
29. D.J. Demanes, A.A. Martinez, and M. Ghilezan et al. High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 81 2011 1286 1292
30. A.A. Martinez, J. Demanes, and C. Vargas et al. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer Am J Clin Oncol 33 2010 481 488
31. C.L. Rogers, S.C. Alder, and R.L. Rogers et al. High dose brachytherapy as monotherapy for intermediate risk prostate cancer J Urol 187 2012 109 116